Daily FNArena News - Small Caps

Tim Boreham highlights the potential for cancer treatment biotech Arovella Therapeutics

Skin repair specialist PolyNovo remains confident in its firm growth path ahead

New research highlights Retail Food Group’s resilience to a consumer downturn and several capital-light growth opportunities

Brokers explain a negative share price reaction to Johns Lyng’s upgraded FY23 guidance

Recent research on Macquarie Technology shows a strong near-term cloud demand outlook and a significant growth profile in coming years

New research identifies Alcidion Group is attaining scale and becoming profitable at an opportune time for healthcare technology demand

New research on Capricorn Metals anticipates growth potential along with consistent profits and increasing dividends over time

Tim Boreham takes a look at Lumos Diagnostics, which specialises in rapid point-of-care tests to help healthcare professionals diagnose and manage medical conditions more accurately

While Sigma Healthcare is a clear winner in gaining the Chemist Warehouse contract from Ebos, the damage is not that significant for Ebos in broker views

PeopleIN’s strategic review failed to realise extra value, nor was a sale forthcoming, but brokers back the company’s decision to stay the course